Updated:
DAYLI Partners
DAYLI Partners is a venture capital firm founded in 2018 in Seoul, South Korea. The firm invests in healthcare sectors including new drugs, bio, medical...
Overview
DAYLI Partners is a venture capital firm founded in 2018 in Seoul, South Korea. The firm invests in healthcare sectors including new drugs, bio, medical devices, and diagnostics. DAYLI Partners has made 79 investments and 6 portfolio exits, with their latest exit being G2G Bio on August 14, 2025.
General information
Firm type
Private Equity
Year founded
2018
Location
Region
Asia
Country
South Korea
City
Seoul
Corporate office
Seoul, South Korea
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: